Posts in category: Featured

Another significant step in the advancement of medical technologies with a partnership between Fourier Intelligence and UNSW Sydney

New South Wales, 16 November 2022 – A Memorandum of Understanding (MoU) has been agreed upon and signed, promoting cutting-edge robotics that can impact lives worldwide.

Fourier Intelligence strives to consolidate the healthcare technology industry by collaborating with key experts across the globe. The team has formed many fundamental partnerships with researchers and clinicians worldwide.

Its MoU with the University of New South Wales (UNSW), Sydney is a pivotal point for the group as it can propel the advancement of rehabilitation technologies to reach a higher potential.

A virtual signing ceremony was held to commemorate the partnership between Fourier intelligence and UNSW. The virtual ceremony was attended by Zen Koh, Co-Founder and Global CEO of Fourier Intelligence; Chen Onn Leong, Manager for Scientific Research; Taya Hamilton, Clinical Consultant, Oceanic Region from Fourier Intelligence; Professor Nigel Lovell, Scientia Professor, Head of the Graduate School of Biomedical Engineering (GSBmE) and Director of Tyree Foundation Institute of Health Engineering (IHealthE), and Dr Thanh Nho Do, Scientia Senior Lecturer from UNSW Sydney.

The UNSW Medical Robotics Lab and other members from Prof. Lovell’s teams are developing state-of-the-art bio-inspired soft robotics, smart textiles, bionic systems, and telehealth, garnering attention from researchers and media worldwide.

“We believe collaboration lies at the heart of unlocking the full potential of this industry,” says Zen Koh, Co-Founder and Global CEO of Fourier Intelligence.

“We are proud to play a key role in driving this rapidly growing field. We are committed to working with Prof. Lovell and Dr Do and their teams to elevate patient experience and optimise the performance of the technologies to deliver positive impact.”

Prof. Lovell says: “This MoU will strengthen the capabilities for research translation within UNSW Engineering, Tyree IHealthE, and GSBmE to create innovative technologies around bionics and bio-robotics that are useful and impactful.”

Dr Do adds: “The forthcoming collaborative projects with Fourier Intelligence will enable us to bring new knowledge creation and scientific inventions from the research laboratory to marketplace.” By joining forces with the talent within GSBME and IHealthE, Fourier Intelligence will be able to investigate and explore how its advanced artificial intelligence technology and control systems can be integrated into the existing clinical devices. The aim is to provide technology that can be customised and individualised to provide effective and efficient therapy for patients.

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

About the University of New South Wales

UNSW’s strategic priorities actively address the challenges we face today – from climate change and renewable energies to lifesaving medical treatments and breakthrough technologies. We aim to make an impact on people’s lives around the world. 

In 2020, UNSW evolved its motto to “Scientia corde mente et manu” – Knowledge by Heart, Mind and Hand. This is more than just a slogan of renewed values and aspirations. It captures the fact that we serve a higher purpose, and are committed to serving society through knowledge sharing and new discovery.

https://www.unsw.edu.au/about-us/our-story

About Tyree IHealthE

Our healthcare system needs to meet the demands of the 21st century. Tyree IHealthE exists to solve our most critical challenges – and improve health outcomes, locally and globally. Tyree IHealthE harnesses the considerable capabilities of UNSW Engineering and UNSW Medicine and Health. Powered by collaboration, Tyree IHealthE is an engine of discovery and research translation.  We are currently establishing the Sydney Consortium for Improving Medicine with Innovation and Technology (SCIMIT). A highly successful initiative, originating in Boston, that brings together clinicians, technologists and industry, SCIMIT will identify unmet healthcare needs and provide a platform for the development of effective new medical technologies.

The uptake of these innovations into mainstream clinical practice is fast-tracked by our strong healthcare partnerships.

https://www.ihealthe.unsw.edu.au/

About UNSW Medical Robotics Lab

In the UNSW Medical Robotics Lab, our research is primarily in the development of Advanced Surgical Systems, Soft Robotics, Wearable Haptics, Soft Exoskeletons, Artificial Organs, Programmable Textile Muscles, Nonlinear Control, and other Medical Devices that contribute to enhance the human quality of life. Our lab is located at Level 1, E26 Biological Sciences South, the Graduate School of Biomedical Engineering, Faculty of Engineering, UNSW, Sydney, Australia. The lab is a place where engineers, neuroscientists, and medical doctors work together to create advanced medical systems, wearable haptic devices, and soft robotic technologies. We design, fabricate, and control surgical robots, soft robotics, haptic devices, and advanced mechatronic systems in medicine more accurate, non-invasive, effective, and at low cost. We also patent our innovative ideas that enable us to transform them from the laboratory to commercial products. Our current major projects include flexible and miniature surgical systems for gastrointestinal cancer and cardiovascular disease treatments, soft robotics, wearable haptics, soft assistive devices, artificial organs, programmable textile muscles, and advanced control systems.

https://www.medicalrobotics-lab.com/

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

Fourier Intelligence, the global leader in rehab tech, announces the launch of its scientific advisory board to promote innovation and growth.

SINGAPORE, 31 October 2022 – Fourier Intelligence, a leading rehabilitation technology company, announced today that it had formed a world-class scientific advisory board to support its innovation and growth.

The board will support Fourier’s continued innovation and growth as a company by providing strategic guidance on emerging technologies and ensuring that the company can meet the growing demands for its products. The advisory comprises top scientists and academics with experience in rehabilitation medicine and technology. They will work closely with Fourier’s leadership team to ensure that the company maintains its position as an industry leader in healthcare technology.

The scientific advisory board will include some of the most prestigious names in medicine and science, including:

Professor Jose L. Pons; Professor Pons is the Scientific Chair of the Legs + Walking Lab of the Shirley Ryan AbilityLab. He is the Director of the Neural Rehabilitation Group in the Department of Translational Neuroscience, CSIC, Spain and co-founder and Vice-President of MotusAcademy. He has coordinated over 15 EU and international research projects with over 400 published peer-reviewed journal articles. Professor Pons is a fellow at the American Institute of Medical and Biological Engineering (AIMBE). With his expertise, he is an associate editor for several journals in neuroprosthesis and neural engineering.

Professor Dario Farina; Professor Farina is the chair of Neurorehabilitation Engineering at the Imperial College of London. In 2018, he obtained an Honorary Doctorate in Medicine from Aalborg University in Denmark. He has received over 10 million Euros of research funding from the European Research Council. Professor Farina founded and directed the Institute of Neurorehabilitation Systems, University Medical Center Gottingen, Germany. He was President of the International Society of Electrophysiology and Kinesiology (ISEK) between 2012 and 2013.

Professor Milos R. Popovic; Professor Popovic is the Director of the KITE Research Institute with the University Health Network (UHN) in Toronto. He was responsible for establishing the Centre for Research in Advances Implant Applications (CRANIA) at the University of Toronto and the UHN Network. In 2004, he co-founded and was co-chair of the Canadian National Spinal Cord Injury Conference. Professor Popovic won first place and the Best Intellectual Property Award at the annual TIEQuest Business Venture for his company, MyndTec Inc.

Professor Robert Riener; Professor Riener is the head of the Sensory Motor Systems Lab at ETH Zürich and a professor of rehabilitation robotics ad the Medical Faculty, University of Zurich, Switzerland. He is the founder and President of CYBATHLON, the world’s first international competition for people with physical disabilities using bionic technology. He is also the current President of the International Consortium of Rehabilitation Robotics (ICORR) and co-founder and President of MotusAcademy. Professor Riener has published over 400 peer-reviewed journals and 24 patents. He has co-directed the National Centre of Competence in Research (NCCR) of Robotics and was or still is a guest professor at several prestigious universities, including the University of Southern California, the Scuola Superiore Sant’Anna and the Shanghai Jiao Tong University.

Professor Denny Oetomo; Professor Oetomo is the Director of the University of Melbourne – Fourier Intelligence Joint Research Laboratory. He is the associate editor for various journals, including the IEEE Robotics and Automation Letters, IEEE Transactions on Mechatronics, ASME Journal of Mechanisms and Robotics, and Mechatronics (Elsevier). He has received and overseen 7 Australian Research Council projects in robotics and human-robot interaction. Professor Oetomo is the lead behind the successful technology transfer of the award-winning upper limb assistive robot, the ArmMotus^TM EMU, with Fourier Intelligence. The robot received the 2022 Red Dot Award, the iF Design Award, the Medical Design Excellence Award, and the “G-Mark” from the Good Design Award.

Dr Manuel Murie Fernández; Dr Fernández is the Medical Director of the Neurorehabilitation Unit of the Hospital ICOT Ciudad de Telde in Spain. He is the head of the neurology service at the San Miguel Clinic, Pamplona, and an Associate Professor at the Public University of Navarra. He completed his fellowship in neurorehabilitation from the University of Western Ontario and has been a mentor for young neurologists in the World Society for Neurorehabilitation. In 2017, Dr Fernández was listed in the Choiseul 100 España as one of the Economic Leaders for Tomorrow. With his expertise, he is sitting on the European Academy of Neurology scientific panel and the editorial board member of Neurología Journal.

Dr Marco Hutter; Dr Hutter is the Director of the Centre for Robotics at ETH Zürich. He is the co-founder of multiple companies, including a board member of ANYbotics AG and Gravis Robotics AG, where he is also CEO. Dr Hutter has won several awards and grants, such as the Branco Weiss Fellowship, ETH medal, IEEE/RAS Early Career Award and ERC Starting Grant. He is the associate editor in a few robotics and automation journals.

Dr Arno Stienen; Dr Stienen is an Associate Professor at the TU Delft, The Netherlands focusing on human augmentation. He was previously the VP of Product Management at DIH Technologies, and Director at Motek Medical B.V. Dr Stienen was the program director of the Professional Doctorate in Engineering in Robotics at the University of Twente, where he obtained his PhD. He publishes research on rehabilitation robotics, human-machine interaction, exoskeletons, and robotics in unstructured and compliant environments.

“We are thrilled to welcome such a distinguished group of experts into our team to support our product development efforts,” said Zen Koh, Co-Founder and Global CEO of Fourier Intelligence. “They bring years of experience in some of our most important areas of innovation, including rehabilitation, machine learning, AI, virtual reality training systems, robotics, and more. Their expertise and experience will help us make sure we are always on track with our goals.”

The board will support the company’s growth and innovation by providing feedback, advice, and insight into product development.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

Fourier Intelligence’s ArmMotus EMU wins yet another award, this time from the Japan 2022 Good Design Award

JAPAN, 14 OCTOBER 2022 – The world-class design award, Good Design Award, has recently announced the 2022 winners. Fourier Intelligence’s ArmMotus™ EMU 3D upper body rehabilitation robot stood out from 5715 entries worldwide and gained a spot with its design concept of “functional design”. This not only represents the affirmation of the international design community for the quality of the medtech brand but also recognises the calibre and patient-first attributes of Fourier Intelligence’s products.

As one of the four major global design awards, the Japan Good Design Award is the most comprehensive and acclaimed in Asia, awarding product designs for 72 years running. Its mission is to discover and share with society those designs that can broaden the fields where design can play a role in creating a richer and more creative life. This year’s theme is “From Cross-Interaction toward Symphony”, which is intended to seek designs that can eliminate tangible or invisible barriers, and a total of 1560 award-winning products have been awarded the “G Mark” logo, symbolising the double guarantee of product design and quality.

The ArmMotus™ EMU is the world’s first three-dimensional back-drivable upper limb rehabilitation robot based on end-effector control, setting a new benchmark for intelligent rehabilitation devices. It adopts an innovative cable-driven mechanism, with a hybrid-series parallel rod structure, and applies lightweight carbon fibre materials, thereby reducing the inertia and friction in the robot’s movement.

The robot adopts the force feedback technology developed by Fourier Intelligence to simulate smoother motor control assist-as-needed actions, mimicking the hands of a therapist. The device is suitable for users with upper limb dysfunction caused by nerve, muscle, or bone injuries. It helps achieve motion control training, task-oriented training, and cognitive training in a three-dimensional space, and is also suitable for training on activities of daily life via human-object interaction. By providing users with real-time and dynamic gravity compensation, it brings on a new experience of rehabilitation assessment and training.

The Good Design Award’s committee states that the functional design of the ArmMotus™ EMU will reduce the burden on therapists performing rehabilitation treatment that usually requires repetitive work. Currently, wearable exoskeleton rehabilitation robots will incur psychological and physical demands on both therapists and patients as it requires time for adjustments on different patients. The innovative structural design of the ArmMotus™ EMU not only achieves effective rehabilitation but also allows more degree of freedom for the patient.

Jointly created by Fourier Intelligence and the University of Melbourne Robotics Laboratory, the ArmMotus™ EMU has continuously honed the innovation by carefully assessing users’ expectations and needs for upper limb rehabilitation training. The device is a combined effort from engineers, researchers, clinicians, and patients. The product has taken six years to finally reach its current product design from a laboratory prototype. With its innovative design, the ArmMotus™ EMU has also won the German Red Dot Design Award, the iF Design Award, the Medical Design Excellence Awards and many more this year alone.

Fourier Intelligence is an industry-leading medical technology company, with its international headquarters in Singapore, striving to make technologies mainstream and fully integrate them into the clinical setting to create positive outcomes. Through years of experience in the field, the team has allied with over 40 global technology companies to expand their product portfolio which now amounts to over 200 products. With more than 30 joint laboratories across the globe and sales partners in over 50 countries around the world, Fourier Intelligence believes it is well-positioned to be at the forefront of providing functional high-performing rehabilitation robotic solutions to improve the quality of life of patients.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

Fourier Intelligence and SensoRehab sign a partnership to improve the reach of rehabilitation technology solutions

SINGAPORE, 20 SEPTEMBER 2022 – Daniel Antipov, SensoRehab’s Commercial and Business Development Director, signed a strategic alliance partnership with Fourier Intelligence’s Co-founder and Global Chief Executive Officer, Zen Koh; Fourier Intelligence’s General Manager, Owen Teoh; and Senior Manager of Fourier Intelligence’s Portfolio Management, Peggy Khoo via Zoom on 19 September 2022.

The virtual event started with short exchanges between the representatives highlighting the partnership’s future and mutual benefits, “Rehabilitation is now possible in your home environment”, stated Zen Koh. “We look forward to working with Daniel and his team to further our mission to provide access to intelligent rehabilitation technologies to empower clinicians and patients globally.”

Daniel Antipov mirrors the sentiments, “We are excited to start our partnership with Fourier Intelligence – one of the leading rehabilitation solutions providers in Asia-Pacific. Both of our companies are looking forward to making efficient advanced medical technologies more accessible to people all over the world. We consider this as a small first step to a great journey in helping people together with Fourier Intelligence”

SensoRehab represents an Information Technology start-up specialising in manufacturing medical devices to rehabilitate neurological diseases such as stroke, Parkinson’s, and Neuropathy. The company has been granted class 1A FDA clearance. SensoRehab’s smart glove is scientifically proven to be 2.5x more effective than the conventional rehabilitation methods.

The partnership will help SensoRehab reach a wider audience via Fourier Intelligence’s international presence and clientele. Specifically, the market presence in the Asia-Pacific region. Furthermore, Fourier Intelligence will continue expanding its upper limb product portfolio while providing additional solutions for home rehabilitation products. SensoRehab provides continuous home rehabilitation through its portable and wireless smart glove rehabilitation complex incorporating more than 20 games with regular updates making rehabilitation enjoyable with accessible software from any PC or laptop.

Fourier Intelligence is building its scope of international partnerships and various rehabilitation solutions via its RehabHub™, where it currently provides 190 rehabilitation products through over 30 global companies, making it the company with one of the largest portfolios and reach of rehabilitation solutions. The expanding growth of Fourier Intelligence’s partnerships strengthens the vision of the company’s RehabHub™ as the most comprehensive catalogue of rehabilitation solutions comprising of robotics therapy, neuromodulation, sensor technology, virtual reality, and functional electrical stimulation.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

Fourier Intelligence exhibited and spoke at the conference signifying the importance of robotics as part of the future of rehabilitation medicine in Malaysia

KOTA BHARU, MALAYSIA, 4 September 2022 – Fourier Intelligence was part of the 13^th Annual Malaysian Rehabilitation Medicine Conference (AMRMC) on 2-3 September 2022, held at the Grand Riverview Hotel, Kota Bharu, Kelantan. The Malaysian Association of Rehabilitation Physicians, Raja Perempuan Zainab II Hospital, Universiti Sains Malaysia Hospital, and Sultan Ismail Petra Hospital jointly organised the event.

The event was held physically after two years of virtual conferences during the COVID-19 pandemic. The 2022 conference theme of “Rehabilitation Medicine: What’s Next?” aims to provide insights into a wide range of innovative existing and future technologies in rehabilitation medicine, highlighting new perspectives and decisions on the services in Malaysia.

Following the conference theme, Fourier Intelligence, alongside distribution partners – Profile Technology Sdn Bhd, showcased what is believed to be the future of rehabilitation medicine through the advancement of technology. The featured products included for the demonstration were BalanceMotus™ KINE-SIM, CycleMotus™ A4, ArmMotus™ EMU, and Myndmove™.

The technology unicorn was one of the lecture speakers on the broad topic of “Robotics in Rehabilitation”, where Dr Leong Chen Onn, Manager, Scientific Research of Fourier Intelligence spoke on the specifics of “Bridging the gap between clinicians and engineers”. The focus area of the speech highlights the symbiotic relationship between health professionals and robotics, where the adoption of robotics can further enable health professionals to identify the best care for patients through objective assessments and interventions. Furthermore, Dr Leong emphasises the need for strong collaboration and feedback between clinicians and engineers to design rehabilitation robotics that meets the needs of both patients and clinicians.

Speaking in the same session is Dr Norhamizan Hamzah Binti Hamzah from University Malaya who has been working on the clinician and engineering gap alongside Dr Leong in some research studies. The pilot study is currently underway and is expected to be published end of next year.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

One of the world’s biggest events to showcase advances in the field of rehabilitation technology has again been sponsored by Fourier Intelligence.

The business, one of the leading names in the rehab tech sector globally, was again a platinum sponsor of RehabWeek, which returned to an in-person event for 2022 and was held in Rotterdam, Netherlands.

The week-long event attracts businesses and professionals from around the world who share a common commitment to driving forward innovation in rehab tech for the benefit of patients globally.

Fourier Intelligence, which also sponsored three of the poster awards, showcased some of its world-leading technology for delegates at the event, which is already changing lives and redefining rehab potential.

RehabWeek was the first showcase of the award-winning lower limb exoskeleton ExoMotus™ M4, as well as showing in person the groundbreaking ArmMotus™ EMU which was soft-launched at last year’s virtual RehabWeek.

It also provided a showcase for the BalanceMotus™ KINE-SIM, a joint launch with KINESIQ, and the prototype of the KINE-Lift was also launched.

RehabWeek also further promoted the RehabHub™, a concept which is in growing use in key venues around the world as a hub for Fourier Intelligence’s suite of life-changing robotic devices.

Fourier Intelligence also held its Global Partnership Summit (GPS) for its sales partners from 30 countries globally, who came together at the event to meet in person after more than two years apart.

The event, which had a packed schedule of workshops and learning opportunities, saw Fourier Intelligence host a workshop on Upper Limb Robotics Group Therapy, hosted by Professor Denny Oetomo, who helped to jointly develop the ArmMotus™ EMU through the university’s collaboration with Fourier Intelligence.

Clinical partners Barrow Neurological Institute also attended and showcased the ArmMotus™ M2 in their own workshops.

“RehabWeek is a very important event for businesses and individuals working in rehabilitation technology around the world, and provides a forum for us to unite and plan for a successful future together,” says Zen Koh, Co-Founder and Deputy Chief Executive of Fourier Intelligence.

“Through collaboration, we will take this sector forward and achieve its full potential, and events like RehabWeek play a key role in making that happen.

“Fourier Intelligence is proud to play a leading role in the ongoing development of rehab tech globally and we are very pleased to share our vision for a successful future with existing and potential collaboration partners.

“This has been another very successful RehabWeek, and particularly to have the opportunity to meet again face to face, and we are delighted to again have lent our support as a platinum sponsor.”

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

Swiss digital healthcare company Akina joins rehab robotics leader Fourier Intelligence’s network of partners.

SWITZERLAND, 21 JULY 2022 – Fourier Intelligence and Akina strengthened their strategic partnership through a Memorandum of Understanding (MoU) signifying the possibility of including Akina’s immersive digital technology into the ever-expanding product portfolio of Fourier Intelligence.

Akina is a leading developer of medical software to empower patients through artificial intelligence-driven motion coaching and digital gamification technology. Starting as a spin-off from Swiss University ETH Zürich, Akina’s growing team believes long-term patient success comes from education and compelling motivation and develops rehabilitation solutions that are engaging and enjoyable for patients. 

A signing ceremony was held to commemorate the partnership between both parties. The partnership was inked and established by Zen Koh (Fourier Intelligence’s Co-Founder and Deputy Group Chief Executive Officer, Owen Teoh(Fourier Intelligence’s General Manager), Florian Haufe (Founder and Chief Executive Officer at Akina), and Michele Xiloyannis (Founder and Chief Technology Officer at Akina).

Commenting on the partnership, Zen Koh of Fourier Intelligence, said, “our partnership with Florian and Michele’s team complements our existing RehabHub™ portfolio and will make the patient’s journey more engaging and fun.”

Florian Haufe of Akina further emphasized that “Fourier Intelligence is a strong partner and platform for Akina to enter the highly attractive SEA market in the future. Together we can dramatically improve patients’ rehabilitation treatment through integrated robotic and digital care.”

In July 2022, Akina secured CHF 150’000 through the Venture Kick award. The partnership brings Akina another exposure platform, leveraging Fourier Intelligence’s vast network of joint labs and clinicians, ensuring a broad market reach for innovative technologies that complement the different markets. Furthermore, the partnership also increases Fourier Intelligence’s capacity to be one of the most comprehensive rehabilitation solution providers through strategic partnerships with over 30 companies, providing over 190 rehabilitation products and solutions.

Fourier’s global network spans over 50 countries, ensuring a broad market outreach for innovative technologies. With joint laboratories with some of the top research institutes in the world, such as ETH Zürich, the University of Melbourne, and Shirley Ryan AbilityLab in Chicago, Fourier is set to chart the new frontier of innovative medical technologies.

Akina will now be part of Fourier Intelligence’s RehabHub^TM. RehabHub^TM is a comprehensive rehabilitation concept equipped with highly efficient, compact, modular, interconnected, and cost-effective robots that deliver efficacious functional training using a combination of group therapy and gamification. Akina will heighten that by offering an immersive digital experience and a more integrated service for therapy at home.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fourierintelligence.com

The growth and potential of the global rehabilitation robotics sector have seen another significant step with a new partnership between Fourier Intelligence and the UK-based National Robotarium.

UNITED KINGDOM, July 15, 2022 – A Memorandum of Understanding has been agreed which will promote knowledge sharing and joint work to create world-leading robotics to benefit the lives of people around the world.

Fourier Intelligence is committed to building the sector and its potential through collaboration with experts around the world and is forming key partnerships with academic and clinical sites on a global scale from its bases in Singapore and Shanghai.

Its MoU with the National Robotarium is the first partnership of its kind in the UK and is seen as having huge potential.

The National Robotarium, in Edinburgh, Scotland, is known as a world-leading centre for the advancement of robotics and in creating innovative technology-led solutions to global challenges, taking research from the laboratory to market.

The partnership between two globally significant names in rehab robotics is the latest step in helping to drive forward the fast-growing sector and to create new solutions in rehabilitation to benefit the lives of those who need them.

“We believe collaboration lies at the heart of unlocking the full potential of this sector,” says Zen Koh, Co-Founder and Deputy Group CEO of Fourier Intelligence.

“This partnership with the National Robotarium is another very significant step in achieving this on a global scale. With the expertise they have here, and their experience in bringing research to market, there is great potential in us working together to deliver the robotic solutions which will benefit patients around the world.” 

“The rehabilitation robotics sector is growing so quickly, and we are proud to be playing a leading role in that. We are committed to working with global partners to advance this further still – through working together, we can deliver positive change.”

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fourierintelligence.com

MPC will adopt the RehabHub™ technology to offer comprehensive rehabilitation solutions encompassing upper limb, lower limb, balance, and movement & coordination.

DUBAI, July 7, 2022 – Fourier Intelligence announces its partnership with MPC to champion the promotions of Fourier’s manufactured rehabilitation robotics devices in Dubai. The partnership will accelerate Fourier’s distribution business across the UAE.

MPC, the leading distributor and healthcare service provider offers a comprehensive portfolio of products and services serving hospitals, medical centres, institutions, retailers, wholesalers, and pharmacies. The company has over 50 years of expertise with long-term support from key healthcare providers within the UAE. MPC provides the strongest back-end support and infrastructure system, machinery, and logistics. With the strategic partnership in place, MPC will incorporate Fourier Intelligence’s RehabHub™ solution to cater intelligent and innovative robotic technology to the patients.

“Our mission is to enable patients to access intelligent and innovative therapy globally”, says Zen Koh. “I am pleased to partner with MPC to advance our distribution across UAE. MPC has a strong track record in the healthcare industry and Fourier is very honoured to partner a leading distributor. This is a significant milestone for Fourier,” the Co-Founder and Deputy Group CEO of Fourier Intelligence states.

Fourier Intelligence’s senior management team will resume their regional interactions and strategic collaborations with market leaders in Europe and the Middle East to offer innovative and clinically effective technology to patients globally.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fourierintelligence.com